Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
B. Palomo Antequera, M. Arias-Guillen, F. Rodríguez Jerez, G. Rubinos Cuadrado, P. Martínez Camblor, J. B. García Casas, P. Casán Clara (Oviedo, Spain). Relationship between risk factors for lung cancer and tumor size. Eur Respir J 2014; 44: Suppl. 58, 2732

Member's Comments

No comment yet.

Related content which might interest you: Methilation status in EBUS-NA samples of lung cancer Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014 Symptom-to-treatment intervals in lung cancer Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Association between leptin and risk of lung cancer Source: International Congress 2016 – Prognostic variables in lung cancer II Year: 2016 Lung cancer in women: Is it different? Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours Year: 2014 Evaluation of lung cancer patients with distant organ metastasis Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Epidemiological changes of patients with lung cancer over Years Source: Annual Congress 2013 –Epidemiology, screening and diagnosis of lung cancer Year: 2013 Assessment of nutritional status in patients with primary lung cancer Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Prognostic factors in non-small cell lung cancer Source: International Congress 2015 – Diagnosis and therapy of lung cancer Year: 2015 Accelerated lung function decline increases the risk of lung cancer Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer Year: 2013 The value of miR221 and miR222 as a biomarker in non small cell lung cancer Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014 Metabolic signatures associated with lung cancer using serum samples. Influence of hemolysis Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014 Lung diseases infection and risk of lung cancer Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer Year: 2013 Metabolomic analysis of serum samples from patients with lung cancer Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014 Lung cancer in England: Trends in survival over the duration of the national lung cancer audit Source: Annual Congress 2013 –Epidemiology of respiratory disease Year: 2013 Second primary lung cancer in squamous NSCLC patients: The Nancy Biobank's database Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours Year: 2014 Weight loss cutoff level as a key variable related to death risk among advanced lung cancer patients Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours Year: 2014 Serum IL-33 as a diagnostic and prognostic marker in non- small cell lung cancer Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014 Does bronchial location of lung cancer influence overall survival? Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015 Prognostic factors for survival in lung cancer Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer Year: 2013 Brain metastatic recurrence following radically treated lung cancer; a retrospective analysis Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014